Lithera adds $6.7M in venture cash; Biostem shuts down;

@FierceBiotech: After Eylea win, Regeneron execs puzzle over R&D scale-up challenge. Article | Follow @FierceBiotech

 @JohnCFierce: Ensemble hasn't raised VC $$ since 2007--which is impressive. Funded by marquee collaborations. | Follow @JohnCFierce

 @EmilyMFierce: ICYMI: NIH confirms it's shelving India drug trials in wake of new regs. Editor's corner | Follow @EmilyMFierce

> San Diego-based Lithera says it has added $6.7 million to its C round, bringing the total to $27.3 million. Release

> Clearwater, FL-based Biostem says it has terminated its last employee and ceased operations. Release

Pharma News

@FiercePharma: Merck taps India's Lupin to market pneumococcal vax under new name. In U.S., brand = Pneumovax 23. More | Follow @FiercePharma

 @CarlyHFierce: Vivus holding its annual meeting this morning. Stay tuned for the end of the proxy fight with First Manhattan--and its outcome. | Follow @CarlyHFierce

> Novartis under U.S. scrutiny for Gilenya marketing tactics. Story

> Deaths force Celgene to stop Revlimid CLL trial in its tracks. News

> Lilly freezes salaries ahead of patent loss for Cymbalta. Report

Medical Device News

@FierceMedDev: Alere's proxy fight gets personal in latest round. More | Follow @FierceMedDev

 @MarkHFierce: The clock is ticking. Send in your 2013 FMD Fierce 15 nominations. Submit now | Follow @MarkHFierce

@DamianFierce: Quest dims revenue outlook as it sells stake in J&J cancer drug. Story | Follow @DamianFierce

> Ex-ArthroCare CEO, CFO finally indicted in $400M fraud scheme. Article

> Hungarian startup seeks med tech partner for intelligent cancer knife. Story

Pharma Manufacturing News

 @EricPFierce: From FierceVaccines.com: ABC's appointment of Jenny McCarthy sparks media furor. News | Follow @EricPFierce

> UAE expects big growth in generic drug production. Item

> Penn Pharma to expand plant opened in May. Report

> China regulators pledge new crackdown on counterfeit drug operations. More

> J&J says it has upped its quality game across all 120 plants. Article

> Cispharma warning letter says injury investigation inadequate. Story

Vaccines News

> Gates-backed device extends cold chain to rural areas. Report

> Bio Farma taps Artes for VLP technology. Item

> ABC's appointment of Jenny McCarthy sparks media furor. More

> New data supports vaccinating gay men against HPV. Story

> Sanofi starts up dengue vaccine plant to maintain edge over Takeda. Article

And Finally… A Purdue University researcher says that T cells in the blood can be converted to create new treatments for autoimmune diseases. Release

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.